N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine
Talarozole
CAS: 201410-53-9
Molecular Formula: C21H23N5S
N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine - Names and Identifiers
N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine - Physico-chemical Properties
| Molecular Formula | C21H23N5S |
| Molar Mass | 377.51 |
| Density | 1.26±0.1 g/cm3(Predicted) |
| Boling Point | 561.0±60.0 °C(Predicted) |
| pKa | 2.70±0.10(Predicted) |
| Storage Condition | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
| In vitro study | When HepG2 cells are cotreated with atRA and Talarozole (1 μM), 4-OH-RA and 4-oxo-RA formation is significantly decreased. |
| In vivo study | A maximum 84% inhibition of CYP26 activity at 0.5 hours post-dose is predicted based on Talarozole (TLZ) C max of 80 nM and a K i of 1 nM following a single dose of Talarozole. Due to the short Talarozole half-life (2.2 hrs) CYP26 activity is predicted to return to 100% by 12 hours. In agreement with the predictions, at RA concentrations are increased by 82, 63 and 60% at 4 hours post-dose in the serum, liver and testes, respectively, and concentrations returned to baseline by 24 hours. Following multiple doses of Talarozole, liver CYP26 mRNA and activity are increased suggesting autoinduction of CYP26 due to increased at RA concentrations. In agreement, at RA concentrations are elevated in serum and liver at all timepoints measured. This increase in at RA concentrations is associated with increased mRNA of the mitochondrial biogenesis markers PGC-1β and NRF-1 in comparison to control mice. |
N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine - Preparation solution concentration reference
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.649 ml | 13.245 ml | 26.489 ml |
| 5 mM | 0.53 ml | 2.649 ml | 5.298 ml |
| 10 mM | 0.265 ml | 1.324 ml | 2.649 ml |
| 5 mM | 0.053 ml | 0.265 ml | 0.53 ml |
Last Update：2024-01-02 23:10:35
![N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine](http://res.chembk.com/assets/images/structure/304255.gif)
Supplier List
Spot supply
Product Name: R115866 Visit Supplier Webpage Request for quotationCAS: 201410-53-9
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: Talarozole Visit Supplier Webpage Request for quotationCAS: 201410-53-9
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Spot supply
Product Name: Talarozole Visit Supplier Webpage Request for quotationCAS: 201410-53-9
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328
WhatsApp: +86-18821248368
Product Name: Talarozole Visit Supplier Webpage Request for quotation
CAS: 201410-53-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
CAS: 201410-53-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Spot supply
Product Name: R115866 Visit Supplier Webpage Request for quotationCAS: 201410-53-9
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: Talarozole Visit Supplier Webpage Request for quotationCAS: 201410-53-9
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Spot supply
Product Name: Talarozole Visit Supplier Webpage Request for quotationCAS: 201410-53-9
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328
WhatsApp: +86-18821248368
Product Name: Talarozole Visit Supplier Webpage Request for quotation
CAS: 201410-53-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
CAS: 201410-53-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
View History
N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine
Deschloro-1,2-dihydro-2-oxo clomiphene HCl
(20β,25R)-3,3-Dimethoxy-5α-spirostane
N-(4-bromophenyl)-2-(3,3-dimethyl-3,4-dihydro-1-isoquinolinyl)-2-(hydroxyimino)acetamide
2-{[4-(diethylamino)benzyl]amino}-N-(2,4-dimethoxyphenyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide
Propanedioic acid, 2-fluoro-2-(3-methylbutyl)-
Deschloro-1,2-dihydro-2-oxo clomiphene HCl
(20β,25R)-3,3-Dimethoxy-5α-spirostane
N-(4-bromophenyl)-2-(3,3-dimethyl-3,4-dihydro-1-isoquinolinyl)-2-(hydroxyimino)acetamide
2-{[4-(diethylamino)benzyl]amino}-N-(2,4-dimethoxyphenyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide
Propanedioic acid, 2-fluoro-2-(3-methylbutyl)-